Docteur Xavier PUECHAL
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
73
h articles cités ≥ h fois chacun. Un h de 73 = 73 publications avec 73+ citations.
Citations
20 759
Publications
518
i10-index
223
Thématiques principales
- Vasculitis and related conditions ×268
- Otitis Media and Relapsing Polychondritis ×85
- Rheumatoid Arthritis Research and Therapies ×59
- Systemic Lupus Erythematosus Research ×58
- Whipple's Disease and Interleukins ×45
Affiliations FR : Université Paris Cité · Hôpital Cochin · Assistance Publique – Hôpitaux de Paris
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis
2026ArticleEuropean Journal of Internal Medicine
Plasma exchange for severe alveolar hemorrhage in ANCA-associated vasculitis: emulation of a target trial
2026ArticleAmerican Journal of Respiratory and Critical Care Medicine
IRF4 haploinsufficiency in a multiplex family with Whipple’s disease
2026ArticleJournal of Human Immunity
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort
2026ArticleArthritis & rheumatology
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling
2025ArticleRMD Open
Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
2025ArticleKidney International Reports
Impact and risk factors of anti-rituximab antibodies in small-vessel vasculitis: a multicenter retrospective study
2025CongrèsACR Convergence 2025
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial
2025ArticleAnnals of Internal Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
GHU APHP CUP SITE COCHIN PORT ROYAL
27 Rue DU FAUBOURG SAINT JACQUES, 75679 Paris 14e Arrondissement
☎ 0158414141Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
Annals of the rheumatic diseases · 2024
- 2Benralizumab for eosinophilic granulomatosis with polyangiitis
Annals of the rheumatic diseases · 2023
📚 35 citations🎯 RCR 4.98Top 8% NIH🔓 Open Access - 3Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort
The Lancet. Rheumatology · 2024
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal20
▼
Transversal20
▼- Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis
European journal of internal medicine · 2026 · Journal Article
Maisons V, Hankard A, Hočevar A, Pillebout E, et al.
- Antineutrophil Cytoplasmic Antibody-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Eshagh D, Quéméneur T, Karras A, Queyrel V, et al.
- Plasma exchange for severe alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: emulation of a target trial
American journal of respiratory and critical care medicine · 2026 · Journal Article
Sanna AC, Gendreau S, Desnos C, Lombardi R, et al.
- Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study
Journal of internal medicine · 2026 · Journal Article
Pallotti F, Mettler C, Papo M, Iudici M, et al.
📚 1 cit.🩺 Clinique - Spondylodiscitis Caused by Tropheryma whipplei: Report of 2 Cases
The Journal of rheumatology · 2026 · Journal Article
Preuss P, Tison A, Cormier G, Puéchal X
- Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study
Rheumatology (Oxford, England) · 2026 · Journal Article
Cioni P, Nguyen Y, Rohmer J, Lacombe V, et al.
- IRF4 haploinsufficiency in a multiplex family with Whipple's disease
Journal of human immunity · 2026 · Journal Article
Ünal S, Dublanc S, Li H, Vernhes JP, et al.
📚 2 cit. - Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling
RMD open · 2025 · Journal Article
Iudici M, Salis Z, Cohen P, Néel A, et al.
- Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
Kidney international reports · 2025 · Journal Article
Vignac M, Nezam D, Grolleau F, Morel P, et al.
📚 2 cit. - Early progression of capillaritis manifestations and poor renal outcome after induction therapy failure in microscopic polyangiitis
Rheumatology (Oxford, England) · 2025 · Journal Article
Sorin B, Nguyen Y, Guerry MJ, Cacoub P, et al.
- Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study
Rheumatology (Oxford, England) · 2025 · Journal Article
Sorin B, Papo M, Sinico RA, Teixeira VS, et al.
📚 2 cit.🩺 Clinique - Whipple's disease: from in-vitro data to bedside practice via trial results
The Lancet. Infectious diseases · 2025 · Journal Article
Puéchal X
📚 3 cit. - Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors
Journal of autoimmunity · 2024 · Journal Article
Sorin B, Papo M, Sinico RA, Teixeira VS, et al.
📚 6 cit.🎯 RCR 1.25🩺 Clinique - Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitis
Rheumatology (Oxford, England) · 2024 · Journal Article
Amsler J, Everts-Graber J, Martin KR, Roccabianca A, et al.
📚 2 cit. - Benralizumab for eosinophilic granulomatosis with polyangiitis
Annals of the rheumatic diseases · 2023 · Journal Article
Cottu A, Groh M, Desaintjean C, Marchand-Adam S, et al.
📚 35 cit.🎯 RCR 4.98🔬→🩺 Translationnel - Finger ischaemia, enlarged spleen and lung nodules
Annals of the rheumatic diseases · 2023 · Journal Article
Puéchal X, Delaval L, Blanche P
- Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomes
Rheumatology (Oxford, England) · 2023 · Journal Article
Sorin B, Iudici M, Guerry MJ, Samson M, et al.
📚 3 cit.🔬→🩺 Translationnel - [Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study]
Revue des maladies respiratoires · 2023 · Observational Study
Akdime F, Habib S, Regard L, Terrier B, et al.
🩺 Clinique - Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis
Rheumatology (Oxford, England) · 2023 · Observational Study
Delestre F, Brun AL, Thoreau B, Taillé C, et al.
📚 2 cit.🩺 Clinique - Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients
Journal of autoimmunity · 2023 · Journal Article
Rohmer J, Nguyen Y, Trefond L, Agard C, et al.
📚 21 cit.🎯 RCR 3.65
Vascularites16
▼
Vascularites16
▼- Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors
Clinical journal of the American Society of Nephrology : CJASN · 2026 · Journal Article
Trivioli G, Allinovi M, Di Marcantonio E, Jawa NA, et al.
📚 1 cit. - Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients
EBioMedicine · 2025 · Journal Article
Pasquiers B, Blanchet B, Puéchal X, Declèves X, et al.
- Glandular Manifestations of the Head and Neck in ANCA-Associated Vasculitides: Data from a National Cohort and Systematic Review
Clinical reviews in allergy & immunology · 2025 · Journal Article
Duhamel N, Puéchal X, Le Gallou T, Chezel J, et al.
- [Recent developments in the treatment of ANCA-associated vasculitides]
La Revue du praticien · 2025 · Journal Article
Puéchal X
- Older age and frailty in ANCA-associated vasculitis: the thin line between undertreating and overtreating
The Lancet. Rheumatology · 2025 · Letter
Thietart S, Puéchal X
- Update on targeted treatments for ANCA-associated vasculitis
Joint bone spine · 2025 · Journal Article
Puéchal X
📚 6 cit.🎯 RCR 2.59🔬→🩺 Translationnel - Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort
The Lancet. Rheumatology · 2024 · Journal Article
Gisslander K, White A, Aslett L, Hrušková Z, et al.
📚 23 cit.🎯 RCR 5.90🔬→🩺 Translationnel - Large-vessel involvement in ANCA-associated vasculitis: A multicenter case-control study
Seminars in arthritis and rheumatism · 2024 · Journal Article
Monghal V, Puéchal X, Smets P, Vandergheynst F, et al.
📚 4 cit. - Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study
Rheumatology (Oxford, England) · 2024 · Multicenter Study
Culerrier J, Nguyen Y, Karadag O, Yasar Bilge S, et al.
📚 5 cit.🎯 RCR 1.53 - Race, Ethnicity, Sex, Gender, Socioeconomic Status, and Representativeness of Race and Ethnicity in ANCA Vasculitis Randomized Trials
Clinical journal of the American Society of Nephrology : CJASN · 2024 · Journal Article
Iudici M, Rueda Sanchez JC, Girard-Guyonvarc'h C, Puéchal X
📚 3 cit. - ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
Rheumatology (Oxford, England) · 2024 · Multicenter Study
Perray L, Nguyen Y, Clavel Refregiers G, Chazal T, et al.
📚 5 cit.🎯 RCR 1.41 - Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
Annals of the rheumatic diseases · 2024 · Journal Article
Delestre F, Charles P, Karras A, Pagnoux C, et al.
📚 37 cit.🎯 RCR 9.00🔬→🩺 Translationnel - Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying
Annals of the rheumatic diseases · 2024 · Meta-Analysis
Gisslander K, Rutherford M, Aslett L, Basu N, et al.
📚 7 cit.🎯 RCR 1.53 - Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study
Journal of autoimmunity · 2024 · Journal Article
Liberatore J, Nguyen Y, Hadjadj J, Cohen P, et al.
📚 10 cit.🎯 RCR 2.29 - Identification of EPX Variants in Human Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
The journal of allergy and clinical immunology. In practice · 2023 · Journal Article
David C, Hamel Y, Smahi A, Diot E, et al.
📚 1 cit. - Characteristics of ANCA-associated vasculitis with aneurysms: Case series and review of the literature
Autoimmunity reviews · 2023 · Journal Article
Hankard A, Puéchal X, Martin Silva N, Deshayes S, et al.
📚 9 cit.🎯 RCR 1.96
Biothérapies non-anti-TNF5
▼
Biothérapies non-anti-TNF5
▼- Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients
EBioMedicine · 2025 · Journal Article
Pasquiers B, Blanchet B, Puéchal X, Declèves X, et al.
- Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial
Annals of internal medicine · 2025 · Journal Article
Terrier B, Pugnet G, de Moreuil C, Bonnotte B, et al.
📚 11 cit.🎯 RCR 4.66🩺 Clinique - Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
Annals of the rheumatic diseases · 2024 · Journal Article
Delestre F, Charles P, Karras A, Pagnoux C, et al.
📚 37 cit.🎯 RCR 9.00🔬→🩺 Translationnel - Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance Therapy
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Randomized Controlled Trial
Khoudour N, Delestre F, Jabot-Hanin F, Jouinot A, et al.
📚 7 cit.🎯 RCR 1.03🩺 Clinique - Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
RMD open · 2023 · Multicenter Study
Mekinian A, Biard L, Lorenzo D, Novikov PI, et al.
📚 8 cit.🎯 RCR 1.30🔬→🩺 Translationnel
Épidémiologie & registres4
▼
Épidémiologie & registres4
▼- Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study
Seminars in arthritis and rheumatism · 2025 · Journal Article
Glatre A, Mahévas T, Jaccard C, Moulis G, et al.
📚 1 cit. - Isolated joint involvement in Whipple's disease: a cohort study
European journal of internal medicine · 2025 · Journal Article
Eiferman V, Chanteloup A, Lagier JC, Puéchal X
📚 3 cit. - Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry
The Journal of infection · 2024 · Journal Article
Caillet Portillo D, Puéchal X, Masson M, Kostine M, et al.
📚 10 cit.🎯 RCR 3.31 - Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual
Arthritis care & research · 2023 · Journal Article
Delvino P, Sardanelli F, Monti S, Cohen P, et al.
📚 4 cit.
Corticothérapie2
▼
Corticothérapie2
▼- Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Papo M, Martinot P, Sinico RA, Silvestre-Teixeira V, et al.
- Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis
Annals of the rheumatic diseases · 2025 · Journal Article
Nagle S, Nguyen Y, Guerry MJ, Quemeneur T, et al.
📚 7 cit.🎯 RCR 2.90🔬→🩺 Translationnel
Vascularites des gros vaisseaux2
▼
Vascularites des gros vaisseaux2
▼- Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study
Rheumatology (Oxford, England) · 2025 · Journal Article
Mekinian A, Meneses S, Biard L, Dagna L, et al.
📚 1 cit. - Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
RMD open · 2023 · Multicenter Study
Mekinian A, Biard L, Lorenzo D, Novikov PI, et al.
📚 8 cit.🎯 RCR 1.30🔬→🩺 Translationnel
Anti-TNF1
▼
Anti-TNF1
▼- Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study
Rheumatology (Oxford, England) · 2025 · Journal Article
Mekinian A, Meneses S, Biard L, Dagna L, et al.
📚 1 cit.
Case report / série1
▼
Case report / série1
▼- Management of Subglottic Stenosis With Tracheostomy in a Surgical Candidate Patient With Granulomatosis With Polyangiitis: A Case Report
Respirology case reports · 2025 · Journal Article
Pakzad Moghadam SH, Abdollahi MH, Xu X, Pourmasumi S, et al.
Essai clinique1
▼
Essai clinique1
▼- Trends in Patient Accrual Rates, Screening Failures, and Related Reasons in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Randomized Controlled Trials
The Journal of rheumatology · 2026 · Letter
Iudici M, Russo B, Puéchal X
IA en rhumatologie1
▼
IA en rhumatologie1
▼- Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis
Kidney international reports · 2025 · Journal Article
Wester Trejo MAC, Sadeghi M, Singh S, Mahmoodian N, et al.
📚 3 cit.
Pharmacovigilance1
▼
Pharmacovigilance1
▼- Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event
Rheumatology (Oxford, England) · 2024 · Case Reports
Sztejkowski C, Sibilia J, Danion F, Mertz P, et al.
Datasets & protocoles partagés
Effect of tumour necrosis factor (TNF) antagonists on anti-mycobacterial proliferative response
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
Expression of membrane-bound tumour necrosis factor (mTNF) after 4 hours of incubation with infliximab (Ifx)
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
Collection2020figshareAbstract Systemic necrotizing vasculitis comprises a group of diseases resembling polyarteritis nodosa and anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA): granulomatosis with polyangiitis, eosinophilic
Expression of membrane-bound tumour necrosis factor (mTNF) after 4 hours of incubation with infliximab (Ifx)
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
Delayed effect of tumour necrosis factor antagonists on lymphocyte proliferation
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
CD4T lymphocytes are the main cells responding to antigens
Image2011figshare<b>Copyright information:</b>Taken from "Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists"Arthritis Research & Therapy 2006;8(4):R114-R114.Published online 19 Jul 2006PMCI
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).